Met expression level in lung adenocarcinoma loosely correlates with met copy number gain/amplification and is a poor predictor of patient outcome

HIGHLIGHTS

• who: Wei Yin and collaborators from the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Changsha, China have published the article: MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome, in the Journal: Cancers 2022, 2433 of /2022/
• what: The aim of this study was to address these questions by correlating with copy number and patient outcome in cohort of 446 patients who had lung adenocarcinoma: 88 with 118 with polysomy 7 and 240 with negative results by fluorescence . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.